1 23 3

Corporate Overview

Corporate Fact Sheet

Platform Fact Sheets

 Cancer Stem-like Cells
 Fc Optimization

In the News...

See what others are writing or saying about MacroGenics. Learn more

Company Highlights

  • Emerging leader in developing therapeutics for immuno-oncology and autoimmune disorders
  • Fully-integrated mAb-based development capabilities, including proprietary technology platforms and protein engineering expertise
  • Differentiated pipeline directed against both novel and validated targets
  • Collaborations with Janssen, Takeda, Gilead, Servier, Boehringer Ingelheim and Pfizer
  • Experienced management team and highly collaborative corporate culture
Learn more


Partnerships have been a critical part of the company’s past growth strategy and will continue to be an emphasis for our future growth strategy. To date, the company has developed significant alliances with leading pharmaceutical and biotechnology companies that enable us to drive forward our proprietary programs, while retaining significant value in the downstream potential of our partnered programs.  Learn more

The company is actively exploring alliances that complement our expertise in biologics product development with important scientific, clinical and business capabilities. These alliances may incorporate our various technology platforms, product candidates and biologic product development capabilities.

To inquire regarding partnership opportunities with MacroGenics, please contact:

Business Development
MacroGenics, Inc.
9640 Medical Center Dr.
Rockville, MD 20850
P: 301.251.5172
F: 301.251.5321
E-mail Business Development